Insider Trades of NELSEN ROBERT Information

Click on the column header to resort ascending (▲) or descending (▼).

Individual Insider Trades

Company Relation Last Date ▼ Type Tran OwnerType Shares Traded Last Price Shares Held
JUNO THERAPEUTICS, INC. Director 04/05/2017 Form 4 Acquisition (Non Open Market) direct 573 0 53,167
AGIOS PHARMACEUTICALS INC Director 03/06/2017 Form 4 Sell indirect 40 49.431
AGIOS PHARMACEUTICALS INC Director 03/03/2017 Form 4 Sell indirect 40,559 50.692 40
AGIOS PHARMACEUTICALS INC Director 02/28/2017 Form 4 Sell indirect 47,859 49.4678 40,599
AGIOS PHARMACEUTICALS INC Director 02/27/2017 Form 4 Sell indirect 195,223 48.3621 88,458
AGIOS PHARMACEUTICALS INC Director 02/23/2017 Form 4 Sell indirect 50,996 47.727 283,681
AGIOS PHARMACEUTICALS INC Director 02/22/2017 Form 4 Sell indirect 47,938 49.9043 334,677
AGIOS PHARMACEUTICALS INC Director 02/21/2017 Form 4 Sell indirect 36,430 50.5576 382,615
JUNO THERAPEUTICS, INC. Director 01/05/2017 Form 4 Acquisition (Non Open Market) direct 659 0 52,594
JUNO THERAPEUTICS, INC. Director 10/05/2016 Form 4 Acquisition (Non Open Market) direct 447 0 51,935
AGIOS PHARMACEUTICALS INC Director 08/08/2016 Form 4 Acquisition (Non Open Market) direct 36,152 0 109,230
SYROS PHARMACEUTICALS, INC. Director 07/06/2016 Form 4 Acquisition (Non Open Market) indirect 4,023,804 0 4,237,137
SYROS PHARMACEUTICALS, INC. Director 07/06/2016 Form 4 Buy indirect 400,000 12.5 4,637,137
JUNO THERAPEUTICS, INC. Director 07/05/2016 Form 4 Acquisition (Non Open Market) direct 335 0 51,488
AGIOS PHARMACEUTICALS INC Director 06/30/2016 Form 4 Acquisition (Non Open Market) direct 25,412 0 73,078
JUNO THERAPEUTICS, INC. Director 04/05/2016 Form 4 Acquisition (Non Open Market) direct 329 0 51,153
SAGE THERAPEUTICS, INC. Director 11/09/2015 Form 4 Disposition (Non Open Market) indirect 500,000 0 1,124,699
SAGE THERAPEUTICS, INC. Director 11/09/2015 Form 4 Acquisition (Non Open Market) direct 25,411 0 107,950
SAGE THERAPEUTICS, INC. Director 09/25/2015 Form 4 Disposition (Non Open Market) indirect 500,000 0 1,624,699
SAGE THERAPEUTICS, INC. Director 09/25/2015 Form 4 Acquisition (Non Open Market) direct 25,412 0 85,539







Create your free portfolio




Most Rated Stocks of Last Week

Rated stocks for NASDAQ, NYSE and AMEX

Symbol / Ratings Consensus

AAPL 86% bullish of 2877 ratings Rate It

DRYS 73% bullish of 45 ratings Rate It

MSFT 84% bullish of 644 ratings Rate It

BAC 75% bullish of 469 ratings Rate It

F 83% bullish of 322 ratings Rate It

INTC 83% bullish of 266 ratings Rate It

NOK 74% bullish of 211 ratings Rate It

BABA 77% bullish of 163 ratings Rate It

GILD 91% bullish of 122 ratings Rate It

PFE 92% bullish of 50 ratings Rate It